Interaction of Tumor Infiltrating Lymphocytes and Cancer Nuclei Predicts Response to Nivolumab in Non-Small Cell Lung Cancer (NSCLC)

被引：1
|
作者：
Wang, X. [1 ]
Barrera, C. [2 ]
Lu, C. [1 ]
Velcheti, V. [3 ]
Madabhushi, A. [1 ]
机构：
[1] Case Western Reserve Univ, Biomed Engn, Cleveland Hts, OH USA
[2] Univ Nacl Colombia, Bogota, Colombia
[3] Cleveland Clin, Pepper Pike, OH USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Prediction response to Nivolumab; Quantitative image analysis; Interaction of TILs and cancer cells;
D O I：
10.1016/j.jtho.2018.08.405
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA11.03
引用
收藏
页码：S393 / S393
页数：1
相关论文
共 50 条
  • [1] Pathological evaluation of tumor infiltrating lymphocytes and the benefit of nivolumab in advanced non-small cell lung cancer (NSCLC)
    Gataa, I.
    Mezquita, L.
    Auclin, E.
    Le Moulec, S.
    Alemany, P.
    Kossai, M.
    Masse, J.
    Caramella, C.
    Masip, J. Remon
    Lahmar, J.
    Ferrara, R.
    Gazzah, A.
    Soria, J-C.
    Planchard, D.
    Besse, B.
    Adam, J.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [2] Importance of tumor infiltrating lymphocytes in non-small cell lung cancer?
    Bremnes, Roy M.
    Donnem, Tom
    Busund, Lill-Tove
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (07)
  • [3] Computer-extracted features relating to spatial arrangement of tumor infiltrating lymphocytes to predict response to nivolumab in non-small cell lung cancer (NSCLC).
    Barrera, Cristian
    Velu, Priya
    Bera, Kaustav
    Wang, Xiangxue
    Prasanna, Prateek
    Khunger, Monica
    Khunger, Arjun
    Velcheti, Vamsidhar
    Romero, Eduardo
    Madabhushi, Anant
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [5] The generation of tumor reactive lymphocytes in non-small cell lung cancer (NSCLC)
    Yannelli, JR
    Wroblewski, JM
    [J]. FASEB JOURNAL, 2002, 16 (04): : A667 - A667
  • [6] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Facing the Reality
    Merimsky, O.
    Shamai, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2425 - S2425
  • [7] Clusters Spatial Arrangement of Tumor Infiltrating Lymphocyte and Cancer Nuclei Predicts Recurrence in Early Stage Non-Small Cell Lung Cancer
    Wang, X.
    Corredor, G.
    Romero, E.
    Schalper, K.
    Yang, M.
    Rimm, D.
    Velcheti, V.
    Madabhushi, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2372 - S2373
  • [8] Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer
    Liu, Hui
    Zhang, Tiantuo
    Ye, Jin
    Li, Hongtao
    Huang, Jing
    Li, Xiaodong
    Wu, Benquan
    Huang, Xubing
    Hou, Jinghui
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (10) : 1849 - 1856
  • [9] Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer
    Hui Liu
    Tiantuo Zhang
    Jin Ye
    Hongtao Li
    Jing Huang
    Xiaodong Li
    Benquan Wu
    Xubing Huang
    Jinghui Hou
    [J]. Cancer Immunology, Immunotherapy, 2012, 61 : 1849 - 1856
  • [10] Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
    Sabine Schmid
    Stefan Diem
    Qiyu Li
    Mirjam Krapf
    Lukas Flatz
    Sebastian Leschka
    Lotus Desbiolles
    Dirk Klingbiel
    Wolfram Jochum
    Martin Früh
    [J]. Cancer Immunology, Immunotherapy, 2018, 67 : 1825 - 1832
12345